Search research articles
Contact Us
Filters
Showing results (61-70 of 153) with videos related to
Page
of 16
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 24, 2017
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [<sup>18</sup>F]-Fluorodeoxyglucose positron emission tomography radiomics features
Mireia Crispin-Ortuzar, Aditya Apte, Milan Grkovski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 4, 2007
Deep-inspiration breath-hold PET/CT: clinical findings with a new technique for detection and characterization of thoracic lesions
Gustavo S P Meirelles, Yusuf Emre Erdi, Sadek A Nehmeh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2011
Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250
Daniel A Pryma, Joseph A O'Donoghue, John L Humm, et al.
Annals of Surgical Innovation and Research
|
February 24, 2009
Portable PET probes are a novel tool for intraoperative localization of tumor deposits
Vivian E Strong, Charles J Galanis, Christopher C Riedl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 19, 2009
Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography
Xiao-Feng Li, Xiaorong Sun, Yuanyuan Ma, et al.
Nuclear Medicine and Biology
|
March 27, 2014
PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients
Irene A Burger, Hebert Alberto Vargas, Aditya Apte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2019
Pharmacokinetic Assessment of <sup>18</sup>F-(2<i>S,</i>4<i>R</i>)-4-Fluoroglutamine in Patients with Cancer
Milan Grkovski, Reema Goel, Simone Krebs, et al.
Cancer
|
March 6, 2002
Rationales, evidence, and design considerations for fractionated radioimmunotherapy
Gerald L DeNardo, Jeffery Schlom, Donald J Buchsbaum, et al.
Translational Oncology
|
August 5, 2017
A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model
Carla Hajj, James Russell, Charles P Hart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2018
<sup>18</sup>F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
Kimiteru Ito, Rebecca Teng, Heiko Schöder, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 153) with videos related to
Sort By:
Page
of 16
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 24, 2017
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [<sup>18</sup>F]-Fluorodeoxyglucose positron emission tomography radiomics features
Mireia Crispin-Ortuzar, Aditya Apte, Milan Grkovski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 4, 2007
Deep-inspiration breath-hold PET/CT: clinical findings with a new technique for detection and characterization of thoracic lesions
Gustavo S P Meirelles, Yusuf Emre Erdi, Sadek A Nehmeh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2011
Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250
Daniel A Pryma, Joseph A O'Donoghue, John L Humm, et al.
Annals of Surgical Innovation and Research
|
February 24, 2009
Portable PET probes are a novel tool for intraoperative localization of tumor deposits
Vivian E Strong, Charles J Galanis, Christopher C Riedl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 19, 2009
Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography
Xiao-Feng Li, Xiaorong Sun, Yuanyuan Ma, et al.
Nuclear Medicine and Biology
|
March 27, 2014
PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients
Irene A Burger, Hebert Alberto Vargas, Aditya Apte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2019
Pharmacokinetic Assessment of <sup>18</sup>F-(2<i>S,</i>4<i>R</i>)-4-Fluoroglutamine in Patients with Cancer
Milan Grkovski, Reema Goel, Simone Krebs, et al.
Cancer
|
March 6, 2002
Rationales, evidence, and design considerations for fractionated radioimmunotherapy
Gerald L DeNardo, Jeffery Schlom, Donald J Buchsbaum, et al.
Translational Oncology
|
August 5, 2017
A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model
Carla Hajj, James Russell, Charles P Hart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2018
<sup>18</sup>F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
Kimiteru Ito, Rebecca Teng, Heiko Schöder, et al.
Page
of 16